Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05593965 · ClinicalTrials.gov registry record · NA
Causal Role of Frontostriatal Circuitry in Goal-directed Behavior
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05593965 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 24 participants.
The verdict
NCT05593965, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to investigate the causal role that frontostriatal circuitry plays in goal-directed behavior. The participants will perform a reward-based decision-making task. During the task, cross-frequency patterned rhythmic transcranial magnetic stimulation (TMS) will be delivered at delta-beta frequency, a control-frequency, or an active sham to either the dorsolateral or medial prefrontal cortex (PFC). Electroencephalography will be collected concurrent with stimulation. Structural and functional magnetic resonance imaging (MRI) will be collected during performance of the reward-based decision-making task to localize the stimulation targets.
Interventions
- DEVICE Arrhythmic TMS
- DEVICE Delta-beta TMS
- DEVICE Theta-gamma TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05593965
The ClinicalTrials.gov registry entry for NCT05593965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arrhythmic TMS is the first listed.
NCT05593965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05593965 about?
NCT05593965 is a clinical study titled "Causal Role of Frontostriatal Circuitry in Goal-directed Behavior". The purpose of this clinical trial is to investigate the causal role that frontostriatal circuitry plays in goal-directed behavior. The participants will perform a reward-based decision-making task. During the task, cross-frequency patterned rhythmic transcranial magnetic stimulation (TMS) will be d...
What is the current status of trial NCT05593965?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-01-10. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05593965?
The interventions under investigation include: Arrhythmic TMS (DEVICE), Delta-beta TMS (DEVICE), Theta-gamma TMS (DEVICE).
Who is sponsoring clinical trial NCT05593965?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.